Faron Pharmaceuticals Oy (LON:FARN - Get Free Report) crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 208.38 ($2.71) and traded as low as GBX 161.28 ($2.09). Faron Pharmaceuticals Oy shares last traded at GBX 177.50 ($2.30), with a volume of 77,081 shares trading hands.
Faron Pharmaceuticals Oy Stock Down 1.4 %
The firm has a market capitalization of £183.09 million, a PE ratio of -546.88 and a beta of 0.36. The company has a current ratio of 1.45, a quick ratio of 1.09 and a debt-to-equity ratio of 922.55. The firm has a 50-day moving average of GBX 207.98 and a two-hundred day moving average of GBX 165.73.
About Faron Pharmaceuticals Oy
(
Get Free Report)
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation.
Featured Stories
Before you consider Faron Pharmaceuticals Oy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Faron Pharmaceuticals Oy wasn't on the list.
While Faron Pharmaceuticals Oy currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
